Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Lymphoma × sapanisertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Ovarian Neoplasms 2 Advanced Nonhematologic Malignancies 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Somatostatinoma 1 Recurrent Lung Squamous Cell Carcinoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Non-hematologic Malignancy 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Hematologic Neoplasms 1 Glioblastoma 1 Fibrolamellar hepatocellular carcinoma 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Burkitt Lymphoma 1 Advanced Solid Tumors 1

Interventions

Rituximab 150 Cyclophosphamide 137 Vincristine 61 Etoposide 61 fludarabine phosphate 60 Doxorubicin 58 Prednisone 56 Filgrastim 50 Cytarabine 46 fludarabine 44 Methotrexate 44 Melphalan 44 Busulfan 42 Whole-Body Irradiation 38 Tacrolimus 33 Mycophenolic Acid 33 Granulocyte Colony-Stimulating Factor 31 Radiotherapy 27 Antilymphocyte Serum 27 Peripheral Blood Stem Cell Transplantation 25 Dexamethasone 24 Carmustine 22 Stem Cell Transplantation 20 Lenalidomide 19 Bortezomib 19 Cyclosporine 18 Gemcitabine 17 thymoglobulin 16 Calcium Dobesilate 16 Alemtuzumab 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02727777 2020-03-12

Phase II Study of TAK228 in Relapsed Lymphoma

M.D. Anderson Cancer Center

Phase 1/2 Terminated

4 enrolled 9 charts

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡